Full Text View
Tabular View
No Study Results Posted
Related Studies
United States Pharmacovigilence Retapamulin-Prescribing
This study is ongoing, but not recruiting participants.
Study NCT01153880   Information provided by GlaxoSmithKline

First Received on June 29, 2010.   Last Updated on April 26, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Skin Infections, Bacterial
Additional conditions recognized in this trial
Bacterial Infections
Skin Diseases, Infectious
More general conditions related to this trial
Infection
Skin Diseases
Interventions listed in this trial
Retapamulin
Additional drug interventions recognized in this trial
Mupirocin
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Protein Synthesis Inhibitors
Therapeutic Uses
Sponsors listed in this trial
GlaxoSmithKline


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services